Find uplifting stories about heroes, innovations, and solutions
2800 results for "flu shot"
Nearly one in three Americans wrongly believe the flu shot can give them the flu, but doctors are setting the record straight with science-backed facts. The confusion stems from mild side effects that actually prove the vaccine is working.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
A new flu vaccine using the same technology that powered COVID shots just proved more effective than traditional options in a 40,000-person study. The breakthrough could reshape how we protect ourselves from seasonal flu.
A breakthrough flu vaccine using the same technology that helped end the COVID-19 pandemic just cleared a major hurdle, potentially offering faster protection for millions of seniors. The FDA's expert panel unanimously recommended approval of Moderna's mRNA flu shot for Americans over 50.
A new flu vaccine that works 27% better than standard shots won unanimous support from FDA advisors, marking a comeback after political interference nearly blocked its review. The mRNA platform could transform how we fight future flu pandemics.
An FDA committee greenlighted next year's flu vaccine formulation this week, maintaining the proven update process while vaccine policy debates swirl in Washington. The decision keeps Americans on track for seasonal flu protection.
After an unexpected rejection last week, the FDA has reversed course and agreed to review Moderna's new mRNA flu vaccine. Seniors could have a new option to protect against the flu by late 2026.
After rejecting Moderna's flu vaccine application just a week ago, the FDA reversed course and will now review the promising mRNA shot. The new technology could revolutionize how we protect ourselves from seasonal flu.
The FDA just greenlit the first mRNA flu shot, bringing the same technology that revolutionized COVID vaccines to your annual flu protection. Adults 50 and older will soon have this new option at their pharmacy.
Scientists at Stanford Medicine have developed a nasal spray vaccine that protects mice against flu, COVID, allergies, and other respiratory threats for months. If it works in humans, one spray each fall could replace multiple annual shots.
A stronger flu vaccine designed for people over 65 could slash Alzheimer's risk in half, offering new hope in the fight against a disease affecting 6 million Americans. The discovery came from researchers analyzing nearly 200,000 older adults.
Older adults who got a high-dose flu vaccine showed up to 20% lower Alzheimer's risk compared to those receiving the standard dose. The finding adds to growing evidence that certain vaccines might protect brain health as we age.
A major study found that older adults who received high-dose flu vaccines showed a 55% lower risk of developing Alzheimer's disease over two years. The finding offers new hope for millions facing dementia while doing something many already do each fall.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
An FDA advisory committee unanimously recommended approval for the first mRNA flu vaccine, marking a major breakthrough that could save thousands of lives and make flu shots faster to produce. The same technology that powered COVID vaccines is now set to revolutionize flu prevention.
Scientists at Washington University have created a nose spray vaccine that completely protected mice and hamsters from bird flu infection, offering hope for preventing the next pandemic. The vaccine works better than traditional flu shots and stays effective even in people who've had previous flu vaccines.
A new type of flu shot using mRNA technology just cleared a major hurdle, bringing us closer to better protection against seasonal flu. The same groundbreaking approach that powered COVID vaccines could soon help millions stay healthier each winter.
Researchers worldwide are developing vaccines that could protect against multiple flu strains for years, ending the need for annual shots. Around a dozen candidates are already in clinical trials.
Getting vaccinated just got simpler for millions. European regulators approved the world's first single-shot vaccine that protects against both COVID-19 and seasonal flu for people 50 and older.
Scientists in the UK and US have started testing a new bird flu vaccine on 4,000 people, taking a proactive step to prepare for potential future pandemics. The vaccine uses the same mRNA technology that proved successful with COVID-19 shots.
Showing 20 of 2800